Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures
Abstract Overweight and obesity are major risk factors for heart failure (HF), contributing to its development through metabolic, neurohormonal, haemodynamic, and inflammatory alterations. While overweight/obesity increases the risk of developing HF, its impact on patient outcomes remains complex. T...
Saved in:
| Main Authors: | Nicola Riccardo Pugliese, Francesco Paneni, Domenico Tricò, Alessandra Violet Bacca, Nicolò De Biase, Hermann Dalpiaz, Alessandro Mengozzi, Agostino Virdis, Lorenzo Ghiadoni, Stefano Taddei, Reinhold Kreutz, Konstantinos Tsioufis, Stefano Masi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Cardiovascular Diabetology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12933-025-02778-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Addressing the Shortage of GLP-1 RA and Dual GIP/GLP-1 RA-Based Therapies—A Systematic Review
by: Velimir Altabas, et al.
Published: (2025-06-01) -
Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure
by: Winston Wang, et al.
Published: (2025-05-01) -
Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP‐1 Receptor Agonists: A Systematic Review and Meta‐Analysis
by: Maheen Asif, et al.
Published: (2025-07-01) -
GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Game Charger in the Field?
by: Georgia Doumani, et al.
Published: (2024-11-01) -
Patients’ experiences with GLP1-RAs – a systematic review
by: Christoffer Kraul Ibsen, et al.
Published: (2025-04-01)